Cardiology

Adverse events not up with six months of DAPT

(HealthDay)—For patients receiving an everolimus-eluting stent implantation, six months of dual antiplatelet therapy (DAPT) does not increase composite events compared with 12 months of DAPT, according to a study published ...

May 19, 2016
popularity1 comments 0

Safety of TAVR examined in all-female cohort

(HealthDay)—In an all-female transcatheter aortic valve replacement (TAVR) registry, 14.0 percent of women experienced a 30-day Valve Academic Research Consortium (VARC-2) composite safety end point, according to a study ...

May 19, 2016
popularity0 comments 0

Research suggests new contributor to heart disease

Medical professionals have long known that the buildup of plaque in arteries can cause them to narrow and harden, potentially leading to a whole host of health problems—including heart attack, heart disease and stroke. ...

May 18, 2016
popularity139 comments 0